Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Shares Outstanding (2020 - 2026)

Nuvalent's (NUVL) quarterly Shares Outstanding (Entity) came in at $73.4 million in Q1 2026, up 10.74% YoY from $66.3 million in Q1 2025, and up 0.88% on a QoQ basis from $72.8 million in Q4 2025.

Analysis

Nuvalent (NUVL) Shares Outstanding (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Shares Outstanding (Entity) data on file, last reported at $73.4 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 10.74% year-over-year to $73.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.4 million (up 10.74% YoY) and the FY2025 annual result came in at $72.8 million, up 10.46% from the prior year.
  • Shares Outstanding (Entity) improved to $73.4 million in Q1 2026, from $72.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $73.4 million in Q1 2026 to a low of $42.9 million in Q1 2022.
  • A 5-year average of $58.2 million and a median of $59.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 1270.93% — and 2025, when it climbed 2.05%.
  • Tracing NUVL's Shares Outstanding (Entity) over 5 years: stood at $51.2 million in 2022, then rose by 14.44% to $58.6 million in 2023, then climbed by 12.42% to $65.9 million in 2024, then climbed by 10.46% to $72.8 million in 2025, then advanced by 0.88% to $73.4 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $73.4 million (Q1 2026), $72.8 million (Q4 2025), and $66.8 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 210.89 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 445.06 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 217.35 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 78.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 78.67 Mn
Dec 31, 2025 72.69 Mn
Sep 30, 2025 72.14 Mn
Jun 30, 2025 71.84 Mn
Mar 31, 2025 71.61 Mn
Dec 31, 2024 66.41 Mn
Sep 30, 2024 65.68 Mn
Jun 30, 2024 64.61 Mn
Mar 31, 2024 64.15 Mn
Dec 31, 2023 58.22 Mn
Sep 30, 2023 57.09 Mn
Jun 30, 2023 56.87 Mn
Mar 31, 2023 56.70 Mn
Dec 31, 2022 49.67 Mn
Sep 30, 2022 48.41 Mn
Jun 30, 2022 48.32 Mn
Mar 31, 2022 48.28 Mn
Dec 31, 2021 21.78 Mn
Sep 30, 2021 32.07 Mn
Jun 30, 2021 3.11 Mn